Foundation’s cancer gene test gets U.S. FDA and Medicare nod

Published 6y ago

CHICAGO (Reuters) – A test from Foundation Medicine Inc that can detect cancer-causing mutations in 324 genes has won approval from the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services, the agencies said. The test, known as F... More »